Communication ResearchNCT07127887
Language Translation of Knowledge Mobilization Resources
A study testing KM Resource - AI and KM Resource - Professional in people with Communication Research, run by University of Alberta at 1 site in Canada.
Trial summary
Knowledge mobilization (KM) resources are tools designed to facilitate the use of research evidence in healthcare decision-making. These resources are created in various formats - including plain language summaries, infographics, and videos - to meet the needs of diverse end-users, such as healthcare professionals… Read more about this study
- Who is it for?
- Ages 18 years and olderHealthy volunteers can take part
- Conditions the study is for
- Communication Research
- What is being tested?
- KM Resource - AI and KM Resource - Professional
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 322 participants
- Where
- 1 siteCanada
- Study dates
- 28 Jul 2025to 22 Nov 2025
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- Healthy volunteers accepted
- Adult, Older adult
Who may be able to join
- • 18 years of age or older
- Living in Canada
- First language is one of the selected languages (i.e. French, Spanish, Ukrainian, Tagalog, Arabic, Chinese, and Punjabi)
- Able to read and complete a questionnaire in English
- Access to an electronic device (e.g. computer or tablet), Internet and email
Who cannot join
- • Under the age of 18 years
- Does not live in Canada
- First language is not one of the selected languages (i.e. French, Spanish, Ukrainian, Tagalog, Arabic, Chinese, and Punjabi)
- Unable to read and complete a questionnaire in English
- No access to an electronic device (e.g. computer or tablet), Internet or email
Trial locations and contacts
1 site in 1 country.
About this study
Official title: Language Translation of Knowledge Mobilization Resources: A Randomized Trial
Knowledge mobilization (KM) resources are tools designed to facilitate the use of research evidence in healthcare decision-making. These resources are created in various formats - including plain language summaries, infographics, and videos - to meet the needs of diverse end-users, such as healthcare professionals, policymakers, patients, and caregivers. They are intended to be easily accessible; however, individuals whose first language is not English may have difficulty understanding them. Thus, translating KM resources into other languages is essential to support health equity and accessibility, but it is often costly and time intensive.
This study aims to explore whether artificial intelligence (AI) tools, specifically ChatGPT - an AI-based large language model developed by OpenAI - can effectively translate KM resources for members of the public whose first language is not English. The resource being evaluated offers guidance on preventing post-COVID-19 condition and has already been translated by a professional (human) translator into seven languages commonly spoken in Canada: French, Spanish, Ukrainian, Tagalog, Arabic, Chinese, and Punjabi. Using ChatGPT, AI-generated translations will be created in those same seven languages.
Read more
For this study, participants - adults living in Canada whose first language is one of the selected languages and able to read English - will be randomly assigned to review either an AI-generated or a professionally translated version of a KM resource. They will then complete a questionnaire evaluating their understanding of the resource, as well as the readability and acceptability of the translation.
This study will contribute to the Investigators' understanding of the potential use of AI for translating health information. The goal is to support equitable access to health information and promote citizen-centered care by reducing language barriers using innovative solutions.
Read the detailed description
Background and Rationale:
KM resources play a critical role in bridging the gap between research and practice in healthcare. Effective communication of this information is essential to ensure the uptake and implementation of research evidence and health recommendations by the public.
Canada is home to a highly diverse population. Language proficiency remains a persistent challenge for many newcomers. Inadequate health communication stemming from language barriers can lead to poorer health outcomes, reduced satisfaction with care, and increased healthcare inequalities. High-quality translations of health materials are therefore essential to promoting equitable access to health information and helping reduce disparities in health outcomes. While professional translation services have long been the standard for producing linguistically accurate translated materials, they are often resource-intensive, limiting the scalability and timeliness of current translation efforts.
Recent advances in AI have generated interest in leveraging AI-powered tools to support the translation of health materials. However, concerns remain regarding the ability of AI powered tools to navigate the cultural, contextual, and emotional nuances of language that are vital in healthcare communication. No controlled trials have yet compared AI and professional translations specifically for KM resources aimed at the public. Empirical assessments of AI-generated translations are therefore essential for understanding its capabilities and limitations.
Objectives:
The overarching research question is: Can AI effectively translate KM resources for the public? For this study, the primary objective is to compare KM resources translated using an AI tool versus those translated by professional human translators. Specifically, the Investigators hypothesize that translations of KM resources produced by ChatGPT will be comparable to professional human translations in terms of understanding, readability, and acceptability.
Methods:
Patient and Public Involvement:
Members of the Pediatric Parent Advisory Group (P-PAG) will provide input throughout the study. They will give input on study design, assist with pilot testing data collection instruments, advise on recruitment strategies, and promote the study within their networks. They will assist with interpreting results and will critically contribute to developing and disseminating findings (e.g., plain language summary of results).
Trial Design:
This study is a randomized controlled trial. Participants will be randomly assigned (1:1 allocation ratio) to receive either an AI-translated version or a professionally translated version of a KM resource. They will be asked to answer a set of questions about their understanding of the content of the resource, its readability and acceptability.
Trial Setting:
The trial will be conducted entirely online. Participants will complete the study remotely using their own personal devices (e.g., computers or tablets) with internet access. All materials, including study link, instructions, and questionnaires, will be delivered electronically.
Eligibility Criteria:
- 18 years of age or older
- Living in Canada
- First language is one of the selected languages (i.e. French, Spanish, Ukrainian, Tagalog, Arabic, Chinese, and Punjabi)
- Able to read and complete a questionnaire in English
- Access to an electronic device (e.g. computer or tablet), Internet and email
Intervention and Comparator:
Participants will be randomized to view a KM resource translated, either by AI (i.e., ChatGPT) or a professional (human) translator, into one of the selected languages. The English-version of the KM resource is available online (https://canpcc.ca/app/uploads/2025/03/Online-Resource-Sheet-GT1-Prevention-of-PCC-Final.pdf).
Outcomes:
The following outcomes will be used to evaluate the translated versions of the KM resource from multiple dimensions: knowledge acquisition (understanding), ease of text processing (readability), and confidence in the information (acceptability).
The primary outcome will be:
Understanding: Measured by participant responses to a set of 7 multiple-choice questions specifically designed to evaluate key content knowledge about post COVID-19 condition and related recommendations contained in the resource. The number of correct answers will serve as an objective indicator of understanding, assessing the ability of each translation method to preserve critical concepts.
Secondary outcomes will be Readability and Acceptability.
Harms:
This study involves little to no risk to participants. Nevertheless, potential harms may include mild fatigue or frustration if participants find the text confusing or difficult to interpret. To minimize this, all materials will be pilot-tested for clarity and presented in a user-friendly format. Participants may withdraw from the study at any time without penalty.
Participant timeline:
Participants in this study will be involved in a single-session conducted online. All data will be collected immediately after the participant has reviewed the assigned translation. Each participant will complete the study in approximately 10-15 minutes. No long-term follow-up is planned.
Sample Size:
Due to the pilot nature of this study, the Investigators aim to recruit 50 participants per language group, with 25 participants randomized to evaluate the AI-translated version and 25 assigned to evaluate the professionally translated version. With seven language groups, the total target sample size will be 350 participants. This sample size follows guidance for exploratory and pilot studies that require no formal sample size calculation. With 50 participants per language group, the Investigators will be able to provide estimates of potential differences while allowing us to explore variations by language.
Recruitment:
Recruitment will begin once the study has received ethics approval. Potential participants will be recruited through a variety of online strategies to ensure broad and diverse enrollment across language groups. Recruitment efforts will include targeted electronic newsletters distributed via University of Alberta's undergraduate and graduate student digests, as well as outreach to international student groups. Additionally, a recruitment email will be sent to pre-established connections to interest-holder groups across Canada to inform them about the study and to ask them to share the study materials within their networks. This may also include asking them to share via traditional means of communication (e.g. e-newsletter, list serv).
Potential participants (self-identified) will be able to access the study directly from the recruitment material by visiting the study link provided. The study link will include detailed instructions to complete the following:
- Answer eligibility screening questions
- Identify their first language
- Review Study Information letter
- Read KM resource to which they have been randomized (AI or professional translation in participant's first language)
- Complete the questionnaire including demographics and responses to questions regarding the KM resource Incentives: Participants will be compensated $5 CAD. This incentive will come in the form of an electronic CAD gift card to the participant via Everything Gift Card.
Recruitment will occur through publicly shared recruitment materials (e.g., email digests, electronic flyers, etc.) containing a study description and a link to the study. Interested individuals will self-identify as potentially eligible and access the study directly by clicking the link. Upon accessing the study link, participants will be presented with a brief set of screening questions to confirm eligibility. Those who do not meet the inclusion criteria will be automatically thanked for their interest and exited from the survey. At the end of the survey, personal information (first name and email) will be shared (if the participant chooses to do so) with the researchers on a separate form, unlinked to the survey responses, for the purposes of gift card distribution. Information collected will be housed separately from the study data in the Gift Card Log.
Randomization and Blinding:
Participants will be stratified by their first language then randomly assigned (1:1 allocation ratio) to one of two groups: the AI-translated KM resource or the professionally translated version. Randomization will be performed at the individual participant level using a computer-generated random allocation sequence to ensure unbiased group assignment.
Participants will be blinded to the type of translation they receive. They will be informed that the study compares different translation methods but will not be told whether the materials they view were translated by AI or by professional translators.
Data Collection and Management:
Data will be collected and managed using REDCap (Research Electronic Data Capture). REDCap has an extensive privacy policy (https://help.redcap.ualberta.ca/policy-procedure/privacy) that has been reviewed by the study team and determined suitable for this study, and has been previously approved for research use at the University of Alberta. Data will be downloaded regularly and stored long-term on a secure server in the PI's faculty (Faculty of Medicine \& Dentistry) at the University of Alberta. Upon completion of the study, the data will be archived on the Faculty of Medicine \& Dentistry server for five years.
Statistical Methods:
The Investigators will collect demographic data (e.g., age, gender, ethnicity, education level, country of birth, health literacy, and proficiency in languages spoken) to describe the study population. The Investigators will use descriptive statistics (numbers, frequencies, means with standard deviations) to analyze and present demographic data. The Investigators will determine overall understanding by calculating a score (ranging from 0 to 7) for each participant based on the number of questions answered correctly. The Investigators will calculate a mean score for each group and compare groups (professional vs. AI translation) using a two-sample t-test assuming equal variances. Other outcomes will be compared between groups using independent t-test or chi squared tests dependent on the type of data (i.e., continuous or categorical). Statistical uncertainties will be expressed with 95% confidence intervals; p<0.05 will indicate statistical significance. Analyses will be conducted based on intention-to-treat, i.e., all available data will be included and the Investigators will not know whether or the extent to which participants read the translated version of the KM tool.
- Conditions
- Communication Research
- Being tested
- KM Resource - AI, KM Resource - Professional
- Keywords
- Knowledge mobilization, Artificial intelligence, Linguistic translation, Cultural diversity, Chat GPT, Health Equity
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
KM Resource - AIOther
The KM resource (an online resource sheet) was developed for the Public Health Agency of Canada about the prevention of post-covid condition (PCC). The resource presents recommendations that were developed by an international group according to standards for guideline development.
The resource has already been AI translated using ChatGPT 4.0 into French as well as six languages common to newcomers across Canada (Arabic, Punjabi, Ukrainian, Tagalog, Chinese, Spanish).
KM Resource - ProfessionalOther
The KM resource (an online resource sheet) was developed for the Public Health Agency of Canada about the prevention of post-covid condition (PCC). The resource presents recommendations that were developed by an international group according to standards for guideline development.
The resource has already been professionally translated into French as well as six languages common to newcomers across Canada (Arabic, Punjabi, Ukrainian, Tagalog, Chinese, Spanish).
| Study group | Role | What they receive |
|---|---|---|
| Group A - AI | Experimental | ChatGPT Receives: Other: KM Resource - AI |
| Group B - Professional | Experimental | Human translator Receives: Other: KM Resource - Professional |
What is being measured
The primary outcome is the main question the study is designed to answer.
Understanding
Measured by participant responses to a set of 7 multiple-choice questions specifically designed to evaluate key content knowledge about post COVID-19 condition and related recommendations contained in the resource. The number of correct answers will serve as an objective indicator of understanding, assessing the ability of each translation method to preserve critical concepts.
Measured: Baseline
Secondary outcomes (2)
Readability
Evaluated using a 5-point Likert scale (1 strongly disagree to 5 strongly agree) assessing clarity, grammar, ease of reading, and terminology, alongside additional open-ended questions identifying confusing or unfamiliar vocabulary
Measured: Baseline
Acceptability
This includes 5-point Likert-scale (1 strongly disagree to 5 strongly agree) ratings of cultural and linguistic appropriateness, comfort in using the resource, and trust in the information presented. Participants will also indicate perceptions about the translation method (human or AI). Acceptability reveals participant confidence and willingness to use the KM resource, which are key determinants of successful health messaging and adherence to recommendations.
Measured: Baseline
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted17 Aug 2025
- Study start28 Jul 2025
- Primary completion22 Nov 2025
- Study completion22 Nov 2025
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Communication ResearchStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Other
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Model description
- Participants will be randomly assigned (1:1 allocation ratio) to receive either an AI-translated version or a professionally translated version of a KM resource.
- Masking
- Double blind
- Who is masked
- Participant, Investigator
- Enrolment
- 322 participants (actual)
Sponsor and investigators
- Lead sponsor
- University of Alberta
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
- Investigators
- Lisa Hartling, PhD, Principal investigator, University of Alberta
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07127887
- Sponsor's protocol ID
- PRO_00153815
- Status last verified
- May 2026
- First submitted
- 6 Aug 2025
- Last updated
- 26 May 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 26 May 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Language Translation of Knowledge Mobilization Resources: A Randomized Trial
- ClinicalTrials.gov ID
- NCT07127887
- Acronym / sponsor ID
- PRO_00153815
- Conditions
- Communication Research
- Keywords
- Knowledge mobilization, Artificial intelligence, Linguistic translation, Cultural diversity, Chat GPT, Health Equity
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 322 participants (actual)
- Lead sponsor
- University of AlbertaUniversity, hospital or other
- Study start
- 28 Jul 2025 (actual)
- Primary completion
- 22 Nov 2025 (actual)
- Study completion
- 22 Nov 2025 (actual)
- First posted
- 17 Aug 2025 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Knowledge mobilization (KM) resources are tools designed to facilitate the use of research evidence in healthcare decision-making. These resources are created in various formats - including plain language summaries, infographics, and videos - to meet the needs of diverse end-users, such as healthcare professionals, policymakers, patients, and caregivers. They are intended to be easily accessible; however, individuals whose first language is not English may have difficulty understanding them. Thus, translating KM resources into other languages is essential to support health equity and accessibility, but it is often costly and time intensive.
This study aims to explore whether artificial intelligence (AI) tools, specifically ChatGPT - an AI-based large language model developed by OpenAI - can effectively translate KM resources for members of the public whose first language is not English. The resource being evaluated offers guidance on preventing post-COVID-19 condition and has already been translated by a professional (human) translator into seven languages commonly spoken in Canada: French, Spanish, Ukrainian, Tagalog, Arabic, Chinese, and Punjabi. Using ChatGPT, AI-generated translations will be created in those same seven languages.
For this study, participants - adults living in Canada whose first language is one of the selected languages and able to read English - will be randomly assigned to review either an AI-generated or a professionally translated version of a KM resource. They will then complete a questionnaire evaluating their understanding of the resource, as well as the readability and acceptability of the translation.
This study will contribute to the Investigators' understanding of the potential use of AI for translating health information. The goal is to support equitable access to health information and promote citizen-centered care by reducing language barriers using innovative solutions.
Detailed description
Background and Rationale:
KM resources play a critical role in bridging the gap between research and practice in healthcare. Effective communication of this information is essential to ensure the uptake and implementation of research evidence and health recommendations by the public.
Canada is home to a highly diverse population. Language proficiency remains a persistent challenge for many newcomers. Inadequate health communication stemming from language barriers can lead to poorer health outcomes, reduced satisfaction with care, and increased healthcare inequalities. High-quality translations of health materials are therefore essential to promoting equitable access to health information and helping reduce disparities in health outcomes. While professional translation services have long been the standard for producing linguistically accurate translated materials, they are often resource-intensive, limiting the scalability and timeliness of current translation efforts.
Recent advances in AI have generated interest in leveraging AI-powered tools to support the translation of health materials. However, concerns remain regarding the ability of AI powered tools to navigate the cultural, contextual, and emotional nuances of language that are vital in healthcare communication. No controlled trials have yet compared AI and professional translations specifically for KM resources aimed at the public. Empirical assessments of AI-generated translations are therefore essential for understanding its capabilities and limitations.
Objectives:
The overarching research question is: Can AI effectively translate KM resources for the public? For this study, the primary objective is to compare KM resources translated using an AI tool versus those translated by professional human translators. Specifically, the Investigators hypothesize that translations of KM resources produced by ChatGPT will be comparable to professional human translations in terms of understanding, readability, and acceptability.
Methods:
Patient and Public Involvement:
Members of the Pediatric Parent Advisory Group (P-PAG) will provide input throughout the study. They will give input on study design, assist with pilot testing data collection instruments, advise on recruitment strategies, and promote the study within their networks. They will assist with interpreting results and will critically contribute to developing and disseminating findings (e.g., plain language summary of results).
Trial Design:
This study is a randomized controlled trial. Participants will be randomly assigned (1:1 allocation ratio) to receive either an AI-translated version or a professionally translated version of a KM resource. They will be asked to answer a set of questions about their understanding of the content of the resource, its readability and acceptability.
Trial Setting:
The trial will be conducted entirely online. Participants will complete the study remotely using their own personal devices (e.g., computers or tablets) with internet access. All materials, including study link, instructions, and questionnaires, will be delivered electronically.
Eligibility Criteria:
- 18 years of age or older
- Living in Canada
- First language is one of the selected languages (i.e. French, Spanish, Ukrainian, Tagalog, Arabic, Chinese, and Punjabi)
- Able to read and complete a questionnaire in English
- Access to an electronic device (e.g. computer or tablet), Internet and email
Intervention and Comparator:
Participants will be randomized to view a KM resource translated, either by AI (i.e., ChatGPT) or a professional (human) translator, into one of the selected languages. The English-version of the KM resource is available online (https://canpcc.ca/app/uploads/2025/03/Online-Resource-Sheet-GT1-Prevention-of-PCC-Final.pdf).
Outcomes:
The following outcomes will be used to evaluate the translated versions of the KM resource from multiple dimensions: knowledge acquisition (understanding), ease of text processing (readability), and confidence in the information (acceptability).
The primary outcome will be:
Understanding: Measured by participant responses to a set of 7 multiple-choice questions specifically designed to evaluate key content knowledge about post COVID-19 condition and related recommendations contained in the resource. The number of correct answers will serve as an objective indicator of understanding, assessing the ability of each translation method to preserve critical concepts.
Secondary outcomes will be Readability and Acceptability.
Harms:
This study involves little to no risk to participants. Nevertheless, potential harms may include mild fatigue or frustration if participants find the text confusing or difficult to interpret. To minimize this, all materials will be pilot-tested for clarity and presented in a user-friendly format. Participants may withdraw from the study at any time without penalty.
Participant timeline:
Participants in this study will be involved in a single-session conducted online. All data will be collected immediately after the participant has reviewed the assigned translation. Each participant will complete the study in approximately 10-15 minutes. No long-term follow-up is planned.
Sample Size:
Due to the pilot nature of this study, the Investigators aim to recruit 50 participants per language group, with 25 participants randomized to evaluate the AI-translated version and 25 assigned to evaluate the professionally translated version. With seven language groups, the total target sample size will be 350 participants. This sample size follows guidance for exploratory and pilot studies that require no formal sample size calculation. With 50 participants per language group, the Investigators will be able to provide estimates of potential differences while allowing us to explore variations by language.
Recruitment:
Recruitment will begin once the study has received ethics approval. Potential participants will be recruited through a variety of online strategies to ensure broad and diverse enrollment across language groups. Recruitment efforts will include targeted electronic newsletters distributed via University of Alberta's undergraduate and graduate student digests, as well as outreach to international student groups. Additionally, a recruitment email will be sent to pre-established connections to interest-holder groups across Canada to inform them about the study and to ask them to share the study materials within their networks. This may also include asking them to share via traditional means of communication (e.g. e-newsletter, list serv).
Potential participants (self-identified) will be able to access the study directly from the recruitment material by visiting the study link provided. The study link will include detailed instructions to complete the following:
- Answer eligibility screening questions
- Identify their first language
- Review Study Information letter
- Read KM resource to which they have been randomized (AI or professional translation in participant's first language)
- Complete the questionnaire including demographics and responses to questions regarding the KM resource Incentives: Participants will be compensated $5 CAD. This incentive will come in the form of an electronic CAD gift card to the participant via Everything Gift Card.
Recruitment will occur through publicly shared recruitment materials (e.g., email digests, electronic flyers, etc.) containing a study description and a link to the study. Interested individuals will self-identify as potentially eligible and access the study directly by clicking the link. Upon accessing the study link, participants will be presented with a brief set of screening questions to confirm eligibility. Those who do not meet the inclusion criteria will be automatically thanked for their interest and exited from the survey. At the end of the survey, personal information (first name and email) will be shared (if the participant chooses to do so) with the researchers on a separate form, unlinked to the survey responses, for the purposes of gift card distribution. Information collected will be housed separately from the study data in the Gift Card Log.
Randomization and Blinding:
Participants will be stratified by their first language then randomly assigned (1:1 allocation ratio) to one of two groups: the AI-translated KM resource or the professionally translated version. Randomization will be performed at the individual participant level using a computer-generated random allocation sequence to ensure unbiased group assignment.
Participants will be blinded to the type of translation they receive. They will be informed that the study compares different translation methods but will not be told whether the materials they view were translated by AI or by professional translators.
Data Collection and Management:
Data will be collected and managed using REDCap (Research Electronic Data Capture). REDCap has an extensive privacy policy (https://help.redcap.ualberta.ca/policy-procedure/privacy) that has been reviewed by the study team and determined suitable for this study, and has been previously approved for research use at the University of Alberta. Data will be downloaded regularly and stored long-term on a secure server in the PI's faculty (Faculty of Medicine \& Dentistry) at the University of Alberta. Upon completion of the study, the data will be archived on the Faculty of Medicine \& Dentistry server for five years.
Statistical Methods:
The Investigators will collect demographic data (e.g., age, gender, ethnicity, education level, country of birth, health literacy, and proficiency in languages spoken) to describe the study population. The Investigators will use descriptive statistics (numbers, frequencies, means with standard deviations) to analyze and present demographic data. The Investigators will determine overall understanding by calculating a score (ranging from 0 to 7) for each participant based on the number of questions answered correctly. The Investigators will calculate a mean score for each group and compare groups (professional vs. AI translation) using a two-sample t-test assuming equal variances. Other outcomes will be compared between groups using independent t-test or chi squared tests dependent on the type of data (i.e., continuous or categorical). Statistical uncertainties will be expressed with 95% confidence intervals; p<0.05 will indicate statistical significance. Analyses will be conducted based on intention-to-treat, i.e., all available data will be included and the Investigators will not know whether or the extent to which participants read the translated version of the KM tool.
Study design
- Primary purpose
- Other
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Double blind (participant, investigator)
- Number of arms
- 2
- Model description
- Participants will be randomly assigned (1:1 allocation ratio) to receive either an AI-translated version or a professionally translated version of a KM resource.
| Arm | Type | Receives |
|---|---|---|
| Group A - AI | Experimental | Other: KM Resource - AIChatGPT |
| Group B - Professional | Experimental | Other: KM Resource - ProfessionalHuman translator |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (5 listed)
- • 18 years of age or older
Key exclusion criteria (5 listed)
- • Under the age of 18 years
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| KM Resource - AIThe KM resource (an online resource sheet) was developed for the Public Health Agency of Canada about the prevention of post-covid condition (PCC). The resource presents recommendations that were developed by an international group according to standards for guideline development. The resource has already been AI translated using ChatGPT 4.0 into French as well as six languages common to newcomers across Canada (Arabic, Punjabi, Ukrainian, Tagalog, Chinese, Spanish). | Other | Group A - AI |
| KM Resource - ProfessionalThe KM resource (an online resource sheet) was developed for the Public Health Agency of Canada about the prevention of post-covid condition (PCC). The resource presents recommendations that were developed by an international group according to standards for guideline development. The resource has already been professionally translated into French as well as six languages common to newcomers across Canada (Arabic, Punjabi, Ukrainian, Tagalog, Chinese, Spanish). | Other | Group B - Professional |
Primary outcome
Understanding
Time frame: Baseline
Measured by participant responses to a set of 7 multiple-choice questions specifically designed to evaluate key content knowledge about post COVID-19 condition and related recommendations contained in the resource. The number of correct answers will serve as an objective indicator of understanding, assessing the ability of each translation method to preserve critical concepts.
2 secondary outcomes
Readability
Time frame: Baseline
Acceptability
Time frame: Baseline
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 26 May 2026.
- Individual participant dataSharing planned: No
Related trials for Communication Research
Active, not recruitingPhase 3
PREVENT HPV -Related Cancers Trial
HPV Vaccination, Uptake Vaccination
RecruitingObservational study
Collection of Clinical Data and Specimens for Research in Hearing, Balance, Taste, Smell, Voice, Speech, and Language Disorders.
Hearing Loss, Deafness
Recruiting
Evaluating AI for the Translation of KM Resources
Communication Research
Recruiting
Empower EI: Comparing Early Intervention Approaches to Improve Communication in Toddlers With Developmental Delays
Developmental Delays
RecruitingObservational study
FOXP1 Syndrome: The Seaver Autism Center for Research and Treatment is Characterizing FOXP1-related Neurodevelopmental Disorders Using Genetic, Medical, and Neuropsychological Measures.
FOXP1, Mental Retardation With Language Impairment and With or Without Autistic Features
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Lisa Hartling, PhD principal investigator
University of Alberta
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing KM Resource - AI and KM Resource - Professional in people with Communication Research, run by University of Alberta at 1 site in Canada.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 5 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 26 May 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Canada. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Understanding (time frame: Baseline). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 26 May 2026.